{"disease":{"id":"chronic-kidney-disease-secondary-hyperparathyroidism","name":"chronic kidney disease secondary hyperparathyroidism"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT05549154","title":"A Study on Prevention Strategies for CKD-SHPT and Related Complications Based on General Vitamin D Supplementation","phase":"NA","overall_status":"UNKNOWN","enrollment_count":372,"lead_sponsor_name":"First Affiliated Hospital Xi'an Jiaotong University","has_results":false},{"nct_id":"NCT00803712","title":"20070360 Incident Dialysis","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":313,"lead_sponsor_name":"Amgen","has_results":true},{"nct_id":"NCT03464149","title":"The Longitudinal PTH-Study","phase":"","overall_status":"COMPLETED","enrollment_count":132,"lead_sponsor_name":"Medical University of Vienna","has_results":false},{"nct_id":"NCT02138838","title":"Efficacy and Safety of Cinacalcet in Pediatric Patients With Secondary Hyperparathyroidism (SHPT) and Chronic Kidney Disease (CKD) on Dialysis","phase":"PHASE3","overall_status":"TERMINATED","enrollment_count":55,"lead_sponsor_name":"Amgen","has_results":true},{"nct_id":"NCT03626246","title":"Pathogenesis of Compromised Bone Quality and Mechanics in Chronic Kidney Disease","phase":"","overall_status":"COMPLETED","enrollment_count":50,"lead_sponsor_name":"Columbia University","has_results":false},{"nct_id":"NCT01277510","title":"Pediatric Chronic Kidney Disease Safety and Efficacy","phase":"PHASE3","overall_status":"TERMINATED","enrollment_count":43,"lead_sponsor_name":"Amgen","has_results":true},{"nct_id":"NCT05880914","title":"Precision Medicine Approaches to Renal Osteodystrophy","phase":"","overall_status":"RECRUITING","enrollment_count":40,"lead_sponsor_name":"Thomas Nickolas","has_results":false},{"nct_id":"NCT01290029","title":"Study to Evaluate Cinacalcet in Children With Chronic Kidney Disease","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":14,"lead_sponsor_name":"Amgen","has_results":true},{"nct_id":"NCT02833857","title":"A Single-dose Study in Paediatric Patients Aged 2 to Less Than 18 Years With Secondary Hyperparathyroidism (sHPT) Receiving Haemodialysis","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":11,"lead_sponsor_name":"Amgen","has_results":true},{"nct_id":"NCT04064827","title":"A Study to Evaluate Safety, Efficacy and Pharmacokinetics of Paricalcitol For Treatment of Secondary Hyperparathyroidism (SHPT) in Pediatric Participants With Stage 5 Chronic Kidney Disease (CKD)","phase":"PHASE3","overall_status":"TERMINATED","enrollment_count":2,"lead_sponsor_name":"AbbVie","has_results":false},{"nct_id":"NCT05543928","title":"Phase 3 Safety and Efficacy Study of CTAP101 Extended-release Capsules in Children With Secondary Hyperparathyroidism","phase":"PHASE3","overall_status":"TERMINATED","enrollment_count":2,"lead_sponsor_name":"OPKO Health, Inc.","has_results":true}],"total":11},"guidelines":[],"source":"Drug Landscape verified database"}